Today: 9 April 2026
Subscribe
Browse Category

NYSE:GEV 23 January 2026 - 4 March 2026

GE Vernova stock edges higher after Italy wind order and $30 million grid plant expansion

GE Vernova stock edges higher after Italy wind order and $30 million grid plant expansion

GE Vernova shares rose 0.8% to $848.76 after announcing new wind and grid equipment deals in Italy, including 17 turbines for IVPC Group’s Fortore wind farm. The company will invest $30 million to expand its Milan-area plant, adding 50 jobs. GE Vernova also closed the $600 million sale of its Proficy software unit to TPG. Equipment shortages and labor constraints continue to affect project timelines.
4 March 2026
···
GE Vernova stock price: GEV’s Friday dip leaves traders watching the Fed, jobs data next

GE Vernova stock price: GEV’s Friday dip leaves traders watching the Fed, jobs data next

GE Vernova shares closed at $873.60 Friday, down 0.33%, after trading between $853.34 and $876.36. The Dow fell 1.05%, S&P 500 lost 0.43%, and Nasdaq dropped 0.92% as U.S. wholesale inflation rose 0.5% in January. GE Vernova warned in January that turbine installation delays at Vineyard Wind could cut revenue and lead to $400 million in losses. The next U.S. jobs report is due March 6.
28 February 2026
··
GE Vernova (GEV) stock tumbles 7% as bond sale settles, even with a fresh Baird upgrade

GE Vernova (GEV) stock tumbles 7% as bond sale settles, even with a fresh Baird upgrade

GE Vernova shares fell 6.6% to $729.05 by midday Wednesday after a streak of record highs, following news of a $2.6 billion bond sale to fund its $5.3 billion Prolec GE acquisition. The stock swung between $728 and $797. Baird upgraded the stock, while Xcel Energy and GE Vernova announced a major turbine and wind project alliance. The company’s wind segment reported a $598 million EBITDA loss for 2025.
4 February 2026
··
GE Vernova stock price hits new high as Prolec GE buyout closes and bond sale starts

GE Vernova stock price hits new high as Prolec GE buyout closes and bond sale starts

GE Vernova closed its $5.28 billion purchase of the remaining Prolec GE stake from Xignux and launched a senior notes offering to help fund the deal. Shares rose 4% to $754.97, holding steady after hours. Fitch and S&P rated the planned debt investment grade. The company’s wind segment reported a $598 million loss for 2025 and expects further losses in 2026.
3 February 2026
···
GE Vernova stock rises as senior notes offering targets Prolec GE deal

GE Vernova stock rises as senior notes offering targets Prolec GE deal

GE Vernova shares rose 3.6% to $752.44 Monday after launching a senior notes offering to help fund its $5.3 billion acquisition of the remaining Prolec GE stake. The company has not disclosed the size or maturity of the bonds. Proceeds will also support general corporate needs. Investors are watching for pricing details and confirmation the Prolec deal closes as scheduled.
2 February 2026
···
GE Vernova stock price: GEV ends week higher as wind risks shadow next session

GE Vernova stock price: GEV ends week higher as wind risks shadow next session

GE Vernova shares closed Friday at $726.37, up 1.3%, after touching $752 intraday and rising 9% for the week. The company raised its 2026 revenue forecast to up to $45 billion and projected wind segment EBITDA losses of about $400 million. Fourth-quarter orders hit $22.2 billion, with a backlog of $150 billion. Missing 11 turbines at Vineyard Wind could cut revenue by over $400 million.
31 January 2026
··
GE Vernova stock price rises after outlook raise; traders eye Feb. 2 Prolec close

GE Vernova stock price rises after outlook raise; traders eye Feb. 2 Prolec close

GE Vernova shares closed up 1.25% at $726.37 Friday, hitting an intraday high of $752.02 before slipping 0.2% after hours. The company warned Vineyard Wind delays could cut $250 million from wind revenue and trigger $400 million in losses if 11 turbines aren’t installed. GE Vernova expects 2026 revenue of $44–$45 billion, above analyst forecasts. The Prolec GE acquisition is set to close Feb. 2.
31 January 2026
··
GE Vernova stock price rises as GEV lifts 2026 outlook, but wind delays keep traders wary

GE Vernova stock price rises as GEV lifts 2026 outlook, but wind delays keep traders wary

GE Vernova shares rose 0.9% to $723.87 Friday after the company raised its 2026 revenue and cash flow forecasts, citing strong turbine and grid demand. The company warned delays at its Vineyard Wind project could cut 2026 revenue by $250 million and deepen losses if more turbines remain uninstalled. Fourth-quarter results showed $11 billion in revenue and $1.8 billion in free cash flow.
30 January 2026
··
GE Vernova stock price rises as Morgan Stanley trims target ahead of earnings

GE Vernova stock price rises as Morgan Stanley trims target ahead of earnings

GE Vernova shares rose 1.7% to $669.04 Monday afternoon ahead of its quarterly earnings report, due before markets open Jan. 28. Morgan Stanley maintained an Overweight rating but lowered its price target to $817. Wall Street expects earnings of $3.03 per share on $10.04 billion revenue. The report coincides with the Federal Reserve’s policy decision Wednesday.
26 January 2026
··
GE Vernova stock price: GEV heads into Jan. 28 earnings after a Friday dip

GE Vernova stock price: GEV heads into Jan. 28 earnings after a Friday dip

GE Vernova shares closed at $657.78 Friday, down 0.6% for the day and 3.5% for the week. The company reports quarterly results Wednesday, Jan. 28, before the U.S. market opens. Investors are watching demand for gas turbines, grid equipment, and cash flow outlooks. Eric Gray will replace Mavi Zingoni as Power segment CEO, with Zingoni staying as adviser until June 30.
25 January 2026
··
1 2 3 … 5

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Go toTop